Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB272572A48

MAGEA9 Antibody (OTI1D8), Alexa Fluor™ 488, Novus Biologicals™
SDP

Catalog No. NB272572A48 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB272572A48 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB272572A48 Supplier Novus Biologicals Supplier No. NBP272572AF488
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

MAGEA9 Monoclonal specifically detects MAGEA9 in Human samples. It is validated for Western Blot.

Specifications

Antigen MAGEA9
Applications Western Blot
Classification Monoclonal
Clone OTI1D8
Conjugate Alexa Fluor 488
Dilution Western Blot
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias Cancer/testis antigen 1.9, CT1.9MAGEA9B, MAGE-9 antigen, MAGE9cancer/testis antigen family 1, member 9, MAGEA9A, melanoma antigen family A, 9, melanoma-associated antigen 9, MGC8421
Gene Symbols MAGEA9
Host Species Mouse
Immunogen Full length recombinant protein of human MAGEA9 (NP_005356) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 4108.0
Target Species Human
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.